Triq Pharmaceuticals Private Limited - Company Profile

It is a paper private limited company based in Khairatabad, Telangana, India, established in 2024.
2024 Khairatabad, Telangana, India Active
Last Updated:
Access Report
About Triq Pharmaceuticals Private Limited

Triq Pharmaceuticals Private Limited, a active private limited company, was established on 04 September 2024 in Khairatabad, Telangana, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21000TS2024PTC189150. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Subrahmanyam Gonupalli (Director), Nikil Dudi (Director), Nagarajan Dudi Suman (Non- Individual Subscriber). Past directors included Nagarajan Dudi Suman. It is based at H No-8-2-269/4/C&D, Road No-2, Sri Nagar Colony, Khairatabad, Telangana, 500034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21000TS2024PTC189150

  • Registration Number

    189150

  • Incorporation Date

    04 September 2024

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 5 Months
Company report

Triq Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Triq Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Triq Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Subrahmanyam Gonupalli Director 04 Sep 2024 Current
Nikil Dudi Director 04 Sep 2024 Current
Nagarajan Dudi Suman Non- Individual Subscriber 04 Sep 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Non- Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Triq Pharmaceuticals.
Triq Pharmaceuticals revenue growth over time
Triq Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Triq Pharmaceuticals?

Unlock access to Triq Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Triq Pharmaceuticals?

Unlock and access historical data on people associated with Triq Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Triq Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Triq Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Triq Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Subrahmanyam Gonupalli was appointed as a Director was appointed as a Director on 04 Sep 2024 & has been associated with this company since 1 year 5 months . was completed.

  • Director Appointment

    The activity Nikil Dudi was appointed as a Director was appointed as a Director on 04 Sep 2024 & has been associated with this company since 1 year 5 months . was completed.

  • Director Appointment

    Nagarajan Dudi Suman was appointed as a Non- Individual Subscriber was appointed as a Non- Individual Subscriber on 04 Sep 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.

  • Company Incorporation

    The activity Triq Pharmaceuticals Private Limited was registered on 04 Sep 2024 with Roc Hyderabad & aged 1 year 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Triq Pharmaceuticals Private Limited?

The CIN of Triq Pharmaceuticals Private Limited is U21000TS2024PTC189150.

Where is Triq Pharmaceuticals Private Limited headquartered?

Triq Pharmaceuticals Private Limited is headquartered at H No-8-2-269/4/C&D, Road No-2, Sri Nagar Colony, Khairatabad, Telangana, 500034.

When was Triq Pharmaceuticals Private Limited incorporated?

Triq Pharmaceuticals Private Limited was incorporated on 04 September 2024.

Who are the current directors of Triq Pharmaceuticals Private Limited?

The current directors of Triq Pharmaceuticals Private Limited are

What is the primary industry of Triq Pharmaceuticals Private Limited?

The primary industry of Triq Pharmaceuticals Private Limited is Paper.

Is Triq Pharmaceuticals Private Limited a listed company?

Triq Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Triq Pharmaceuticals Private Limited?

The authorized capital of Triq Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available